A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines.
Phase of Trial: Phase II/III
Latest Information Update: 24 Dec 2015
At a glance
- Drugs Lopinavir/ritonavir (Primary) ; Nucleoside reverse transcriptase inhibitors
- Indications HIV-1 infections
- Focus Adverse reactions; Pharmacokinetics
- 07 Jun 2017 Biomarkers information updated
- 21 Sep 2015 Results presented at the Joint 55th Interscience Conference on Antimicrobial Agents and Chemotherapy and 28th International Congress of Chemotherapy
- 17 Feb 2014 According to the ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.